A medical linear accelerator (LINAC) is a giant machine that zaps tumours with high‑energy X‑rays. It's the workhorse of radiation oncology. The medical linear accelerator market report by MRFR shows that high‑energy LINACs are the largest segment, and the market is growing at 4.26% CAGR — from $6.04 billion to $9.56 billion by 2035. Why the steady growth? Because cancer rates are rising, and radiation therapy is a cornerstone of treatment.

What's driving growth? Radiation therapy is the largest application, but stereotactic body radiation therapy (SBRT) is the fastest‑growing — it delivers high doses in 1‑5 sessions. The medical linear accelerator market analysis highlights that hospitals are the largest end‑user segment, but cancer centers are the fastest‑growing — as specialised oncology clinics expand.

What's new? MR‑linac (MRI combined with LINAC) that images the tumour in real time, adjusting the beam as the patient breathes. Also, FLASH radiotherapy that delivers ultra‑high dose in milliseconds, sparing healthy tissue.

The bottom line: if you have cancer, radiation therapy is a powerful tool. And the LINAC is the machine that delivers it. Modern LINACs are precise, safe, and increasingly intelligent.